Intellia Therapeutics, Inc. (NTLA)
11.74
-0.19
(-1.59%)
USD |
NASDAQ |
Sep 11, 16:00
11.77
+0.03
(+0.26%)
After-Hours: 20:00
Intellia Therapeutics Price to Book Value : 2.259 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 2.259 |
| September 10, 2026 | 2.296 |
| September 09, 2026 | 2.349 |
| September 08, 2026 | 2.451 |
| September 04, 2026 | 2.451 |
| September 03, 2026 | 2.440 |
| September 02, 2026 | 2.455 |
| September 01, 2026 | 2.441 |
| August 31, 2026 | 2.449 |
| August 28, 2026 | 2.476 |
| August 27, 2026 | 2.522 |
| August 26, 2026 | 2.538 |
| August 25, 2026 | 2.600 |
| August 24, 2026 | 2.417 |
| August 21, 2026 | 2.471 |
| August 20, 2026 | 2.394 |
| August 19, 2026 | 2.555 |
| August 18, 2026 | 2.232 |
| August 17, 2026 | 2.326 |
| August 14, 2026 | 2.292 |
| August 13, 2026 | 2.276 |
| August 12, 2026 | 2.326 |
| August 11, 2026 | 2.313 |
| August 10, 2026 | 2.313 |
| August 07, 2026 | 2.297 |
| Date | Value |
|---|---|
| August 06, 2026 | 2.163 |
| August 05, 2026 | 2.111 |
| August 04, 2026 | 2.178 |
| August 03, 2026 | 2.072 |
| July 31, 2026 | 2.055 |
| July 30, 2026 | 2.134 |
| July 29, 2026 | 2.078 |
| July 28, 2026 | 2.095 |
| July 27, 2026 | 2.053 |
| July 24, 2026 | 2.065 |
| July 23, 2026 | 2.136 |
| July 22, 2026 | 2.142 |
| July 21, 2026 | 2.207 |
| July 20, 2026 | 2.101 |
| July 17, 2026 | 2.189 |
| July 16, 2026 | 2.282 |
| July 15, 2026 | 2.509 |
| July 14, 2026 | 2.559 |
| July 13, 2026 | 2.505 |
| July 10, 2026 | 2.735 |
| July 09, 2026 | 2.971 |
| July 08, 2026 | 3.240 |
| July 07, 2026 | 3.354 |
| July 06, 2026 | 3.433 |
| July 02, 2026 | 3.379 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Twist Bioscience Corp. | 17.89 |
| Beam Therapeutics, Inc. | 2.321 |
| Moderna, Inc. | 8.496 |
| Revolution Medicines, Inc. | 16.75 |
| Sana Biotechnology, Inc. | 6.061 |
Price to Book Value Related Metrics
| PS Ratio | 23.58 |
| Price | 11.74 |
| Earnings Yield | -28.59% |
| Market Cap | 1.644B |